Stereotactic Injection of Shrna GSK-3β-AAV Promotes Axonal Regeneration after Spinal Cord Injury

Yu-chao Zuo,Nan-xiang Xiong,Hong-yang Zhao
DOI: https://doi.org/10.1007/s11596-016-1623-6
2016-01-01
Acta Academiae Medicinae Wuhan
Abstract:Evidence suggested that glycogen synthase kinase-3β (GSK-3β) is involved in Nogo-66 inhibiting axonal regeneration in vitro, but its effect in vivo was poorly understood. We showed that stereotactic injection of shRNA GSK-3β-adeno associated virus (GSK-3β-AAV) diminished syringomyelia and promoted axonal regeneration after spinal cord injury (SCI), using stereotactic injection of shRNA GSK-3β-AAV (tested with Western blotting and RT-PCR) into the sensorimotor cortex of rats with SCI and by the detection of biotin dextran amine (BDA)-labeled axonal regeneration. We also determined the right position to inject into the sensorimotor cortex. Our findings consolidate the hypothesis that downregulation of GSK-3β promotes axonal regeneration after SCI.
What problem does this paper attempt to address?